Cohort Studymoderate evidence

Testosterone replacement therapy increases 2 and 5 year reoperation rates after posterior lumbar fusion: a propensity-matched analysis of 1808 surgical patients.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·September 1, 2026·PMID 42172893

Why it matters

With rising TRT use, spine surgeons need evidence to counsel patients on long-term surgical expectations. This study identifies TRT as a potential marker for higher reoperation risk, aiding in risk stratification and postoperative surveillance.

Infographic summary of Testosterone replacement therapy increases 2 and 5 year reoperation rates after posterior lumbar fusion: a propensity-matched analysis of 1808 surgical patients.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled